Prognostic significance of neutrophil-to-lymphocyte ratio in cervical cancer: A systematic review and meta-analysis of observational studies

Oncotarget. 2017 Mar 7;8(10):16755-16764. doi: 10.18632/oncotarget.15157.

Abstract

Background and aims: The prognostic role of neutrophil-to-lymphocyte ratio (NLR) in cervical cancer are controversial. We conducted this meta-analysis to obtain a more accurate assessment of prognostic significance of NLR in cervical cancer.

Results: A total of 9 studies, consisting of 2,804 patients, were selected in this meta-analysis. Our pooled results showed that high pre-treatment NLR level was significantly associated with poorer overall survival (HR: 1.88, 95% CI 1.30-2.73) and shorter progression free survival (HR 1.65, 95% CI 1.18-2.29). Additionally, increased NLR was also significantly correlated with tumor size (OR 2.05, 95% CI 1.14-3.65), advanced FIGO stage (OR 2.12, 95% CI1.28-3.49) and lymph node involvement (OR 2.24, 95% CI 1.65-3.04).

Materials and methods: We conducted a systematic literature search using the electronic databases PubMed, Web of Science, and Embase up to May 2016.Statistical analysis was performed using Stata 10.0.

Conclusions: Elevated pretreatment NLR could serve as a predicative factor of poor prognosis for cervical cancer patients.

Keywords: cervical cancer; inflammatory; lymphocyte; neutrophil; prognosis.

Publication types

  • Meta-Analysis
  • Review
  • Systematic Review

MeSH terms

  • Female
  • Humans
  • Lymphocytes / pathology*
  • Neutrophils / pathology*
  • Observational Studies as Topic
  • Prognosis
  • Survival Analysis
  • Uterine Cervical Neoplasms / blood*
  • Uterine Cervical Neoplasms / pathology